Literature DB >> 8541242

The cost of cognitive impairment in schizophrenia.

S Sevy1, M Davidson.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8541242     DOI： 10.1016/0920-9964(95)00025-h

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  15 in total

1.  Hippocampal place cell and inhibitory neuron activity in Disrupted-in-schizophrenia-1 mutant mice: implications for working memory deficits.

Authors:  Lia Mesbah-Oskui; John Georgiou; John C Roder
Journal:  NPJ Schizophr       Date:  2015-04-01

Review 2.  Olanzapine. A pharmacoeconomic review of its use in schizophrenia.

Authors:  R H Foster; K L Goa
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 3.  Cognition in schizophrenia.

Authors:  P D Harvey; C R Bowie; J I Friedman
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

4.  Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: timing and patterns.

Authors:  César González-Blanch; Mario Alvarez-Jiménez; José Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; José Luis Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

Review 5.  Risperidone. A pharmacoeconomic review of its use in schizophrenia.

Authors:  R H Foster; K L Goa
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 6.  Effect of second-generation antipsychotics on cognition: current issues and future challenges.

Authors:  S Kristian Hill; Jeffrey R Bishop; Donna Palumbo; John A Sweeney
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

Review 7.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 8.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

9.  The influence of social interaction on cognitive training for schizophrenia.

Authors:  Jennifer Louise Cook; Jennifer Black
Journal:  Front Neurosci       Date:  2012-09-28       Impact factor: 4.677

10.  Evaluation of efficacy, safety, and cognitive profile of amisulpride per se and its comparison with olanzapine in newly diagnosed schizophrenic patients in an 8-week, double-blind, single-centre, prospective clinical trial.

Authors:  Ganesh R Pawar; P Phadnis; A Paliwal
Journal:  ISRN Psychiatry       Date:  2012-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.